论文部分内容阅读
目的研制良性前列腺增生患者生命质量测定量表(QLICD-BPH)并对其进行评价。方法依据慢性病患者生命质量测定量表体系共性模块与特异模块相结合的研究思想,在对文献回顾的基础上,结合中国文化特色,采用量表开发的程序化决策方式研制量表,并通过测试141例良性前列腺增生(BPH)患者的生命质量对量表进行评价。结果 QLICD-BPH量表的重测信度为0.95;Cronbach’sα系数为0.91;分半信度为0.72;相关分析和因子分析显示有较好的结构效度,反应度也尚可;各条目与其所在领域的相关均大于与其他领域的相关,相关系数r值多>0.5。结论 BPH患者QLCID-BPH量表具有较好的信度、效度和反应度,可以作为临床BPH患者的测评工具。
Objective To develop and evaluate the quality of life scale (QLICD-BPH) for patients with benign prostatic hyperplasia (BPH). Methods According to the research thought of combining the common module and the specific module of chronic disease quality of life measurement system, based on the review of the literature, combined with the characteristics of Chinese culture, the scale was developed by using the program-based decision-making method of scale development and passed the test The quality of life of 141 patients with benign prostatic hyperplasia (BPH) was evaluated on the scale. Results The retest reliability of the QLICD-BPH scale was 0.95; the Cronbach’s α coefficient was 0.91; the half-reliability was 0.72; correlation analysis and factor analysis showed good structural validity and good reactivity; Correlations with their fields are greater than those with other fields, and the correlation coefficient r is more than 0.5. Conclusion The QLCID-BPH scale in patients with BPH has good reliability, validity and responsiveness and can be used as a measurement tool in clinical BPH patients.